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bstract
Recent evidence has shown that reactive oxygen species (ROS), inflammation and the activation of JAK/STAT signalling are
ajor pathways in the induction and progression of renal ischaemia/reperfusion (I/R) injury. The protective effect of Xanthohumol
XN) against I/R induced renal injury has not been investigated. Hence, this study aimed to investigate the in  vivo  effect of XN
gainst renal I/R injury. The rats used in this study were divided into 2 main groups of either 1) sham-operated or 2) subjected to renal
/R, in which each group was further divided into 2 subgroups: treated with oral administration of normal saline or XN (1 mg/kg) for
8 days. Renal function, histology, markers and expression levels of oxidative stress, inflammation and apoptosis were examined.
he expression levels of the activated JAK-2/Stat-3 signalling pathway were also assessed. XN treatment in the sham group resulted
n a normal response, as seen in the sham operated as control group. However, XN significantly improved renal function and
ttenuated histological changes by reducing the levels of oxidative stress and lipid peroxidation, inflammatory markers, adhesive
olecules and the activity of myeloperoxidase (MPO). Concomitantly, reduced expression levels of activated caspase with a parallel
ecrease in JAK-1/Stat-3 phosphorylation were also noticed. In conclusion, these findings show, for the first time, a protective effect
f XN against renal I/R injury, and the mechanisms of protection involve ROS scavenging and an anti-inflammatory effect mediated
y the inhibition of the JAK-2/STAT-3 pathway.
 2016 Taibah University. Production and hosting by Elsevier B.V. This is an open access article under the CC BY-NC-ND license
http://creativecommons.org/licenses/by-nc-nd/4.0/).
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1.  Introduction
Renal injury as a result of ischaemia reperfusion
(I/R), which usually occurs after renal transplantation,
shock, sepsis, and renal artery stenosis, is considered
a major cause of acute renal failure (ARF) and is
responsible for more than 50% of global mortalityol protects against renal ischaemia reperfusion (I/R)
 inflammatory pathway, J. Taibah Univ. Sci. (2016),
. This is an open access article under the CC BY-NC-ND license
[1]. A high generation rate of reactive oxygen species
(ROS), endothelial cell injury, and apoptosis have been
shown to be implicated in the pathogenesis of the early
phases of renal ischaemia/reperfusion (I/R) injury [2].
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In addition, there is accumulating evidence that I/R
injury results in inflammatory disease, as manifested by
the infiltration of leucocytes, up-regulation of chemo-
tactic factors by endothelial cells and generation of
pro-inflammatory mediators by renal tubular epithelial
cells [3].
During early I/R events, a massive influx of neu-
trophils after reperfusion occurs which result in the
release of cytotoxic proteases and exacerbates the gen-
eration of ROS that worsen the oxidative damage
[3,4], making apoptosis a common form of death of
renal cells [5]. This process is enhanced due to the
overexpression of endothelial cell adhesion molecules
such as intracellular cell adhesion molecules (ICAMs),
complement components such as C5a, and a num-
ber of chemokines including monocyte chemoattractant
protein-1 (MCP-1) (of which the murine homologue is
keratinocyte-derived chemokine (KC)) and macrophage
inflammatory protein-2 (MIP-2) [3].
On the other hand, the JAK/STAT pathway is com-
posed of a family of receptor-associated cytosolic
tyrosine kinases (JAKs) that phosphorylate a tyrosine
residue on bound transcription factors (STATs) [6]. Once
phosphorylated, STAT family members are translocated
to the nucleus where they augment gene transcription [7].
The activation of the JAK/STAT pathway has been con-
firmed as a major pathway involved in the development
of renal I/R injury, during which many pro-inflammatory
cytokines and adhesive molecules are up-regulated [6].
Activation of the JAK/STAT pathway mediates the up-
regulation of MCP-1 and ICAM [8]. It has been found
that the expression of MCP-1 and ICAMs is blocked
by JAK/STAT inhibitors, resulting in decreased levels of
ROS and inflammation under various conditions [8–10].
Xanthohumol (XN, 3-[3,3-dimethylallyl]-2,4,4-
trihydroxy-6-methoxychalcone) is the principal
prenylated chalcone of the female inflorescences (hop
cones, hops) of the hop plant Humulus  lupulus  L. Hops
(Humulus lupulus  L.) flowers (Fig. 1A,B) are widely
used throughout the world as a raw material in the
brewing industry, to preserve beer and to give beer its
characteristic aroma and flavour. In addition to their
application in the brewing industry, hops have for a
long time been used for various medical purposes [11].
Although XN has been traditionally used since ancient
times to treat pain and improve appetite and diges-
tion, recent studies have confirmed the ability of this
flavonoid to treat various medical disorders includingPlease cite this article in press as: A.A. Shati. Xanthohum
injury by scavenging ROS and inhibition of JAK-2/STAT-3
http://dx.doi.org/10.1016/j.jtusci.2016.09.009
cancer [11]. Very recently, numerous studies have shown
a protective effect of XN against ischaemia-related
disorders due to its antioxidant and anti-inflammatory
actions. In cerebral ischaemic rats, XN resulted in a PRESS
 for Science xxx (2016) xxx–xxx
reduction of the infarct volume and the improvement
of neuro-behaviours due to its antioxidant and anti-
inflammatory roles (i.e., decrease of hypoxia-inducible
factor-1  (HIF-1), iNOS expression, and free radical
formation), apoptosis (i.e., TNF-, active caspase-3)
and platelet activation [12]. Additionally, XN reduced
liver damage in a mouse model of warm I/R injury in a
mechanism related to the inhibition of proinflammatory
genes including IL-6, MCP-1 and ICAM-1 [13].
To our knowledge, the protective effect of XN against
I/R induced renal injury has not been investigated. More-
over, the anti-inflammatory role of XN being mediated
by inhibition of the JAK/STAT pathway has not been
studied. Therefore, given the important role of ROS and
the JAK/STAT pathway in the development and pro-
gression of renal I/R injury and the antioxidant and
anti-inflammatory effects of XN, this study aimed to
investigate the protective role of XN against renal I/R
injury and to investigate if such an effect is mediated
through inhibition of the JAK/STAT pathway.
2.  Materials  and  methods
2.1.  Chemicals
Xanthohumol (XN, Cat. No. X0379) was obtained
from Sigma Aldrich (St Louis, MO, USA), with a purity
≥96% determined by HPLC and was freshly prepared
in normal saline to the final concentration used in the
experimental procedure.
2.2.  Animals
This study was performed between March 2015 and
Decembers 2015. Forty male Wistar rats aged 12 weeks
and weighing 250 ±  10 g from the same lineage and
breeding stock were obtained from the animal house of
the College of Science at King Khalid University (Abha,
Saudi Arabia) and housed (5 rats/cage, 2 cages/group)
under controlled conditions (temperature of 23 ±  1 ◦C,
and a 12 h light:12 h dark cycle). The animals were
allowed free access to normal chow and tap water. The
experiments were performed according to the Guide for
the Care and Use of Laboratory Animals published by
the US National Institutes of Health (NIH publication
No. 85-23, revised 1996). All experimental procedures
in this study were approved by the ethical committee of
the College of Science at King Khalid University.ol protects against renal ischaemia reperfusion (I/R)
 inflammatory pathway, J. Taibah Univ. Sci. (2016),
2.3.  Experimental  design
The rats were divided into four groups each of 10 rats
and classified as follows: (1) Sham group: Pre-treated
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Dig. 1. Kidney function parameters in the serum and urine of all gro
onsidered significantly different at P < 0.05. (a) Significantly differen
o Sham + XN group. (c) Significantly different when compared to I/R
ith normal saline for 28 consecutive days and then
xposed to the surgical procedure only as that in I/R
xposed rats but without clamping the renal arteries; (2)
ham group + XN: Pre-treated with XN (1 mg/kg b.w)
or 28 consecutive 28 and then exposed to surgical
rocedure only as in group 1; (3) I/R group: received
ormal saline for 28 days and then exposed to renal I/R
s discussed below; (4): Xanthohumol (XN) pre-treatedPlease cite this article in press as: A.A. Shati. Xanthohum
injury by scavenging ROS and inhibition of JAK-2/STAT-3
http://dx.doi.org/10.1016/j.jtusci.2016.09.009
roup (XH + I/R): pre-treated with XN (1 mg/kg b.w)
or 28 days and then exposed to renal I/R on day 28.
However, selection of this dose was based on
orn’s study [13] that showed an antioxidant andues are expressed as the means ± SD for 10 rats/group. Values were
 compared to Sham group. (b) Significantly different when compared
anti-inflammatory protective role of XN against hepatic
I/R injury at a similar dose. However, it is important
to mention here that XN has been well tolerated and
is considered safe, even at very high doses (up to
1000 mg/kg), as this dose did not affect the major
organ functions, homoeostasis, or the protein, lipid, and
carbohydrate metabolism in rats [14].ol protects against renal ischaemia reperfusion (I/R)
 inflammatory pathway, J. Taibah Univ. Sci. (2016),
2.4.  Induction  of  renal  I/R  injury
By the end of the treatment period, on day 28,
I/R injury was performed under sodium pentobarbital
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anaesthesia (60–70 mg/kg, intraperitoneally) (Sigma
Life Science, St Louis, MO, USA) where an abdominal
incision was made and the renal vessels on both sides
were identified. The renal arteries were bilaterally
occluded with a micro-vascular clamp for 60 min.
Then, the clamps were removed, and blood flow to
the kidneys was re-established. The surgical incision
was sutured, and rats were allowed to recover for 48 h
with free access to food and water only. Groups 1
and 2 underwent the same surgical procedure without
IR.
2.5.  Blood,  urine  and  tissue  collection
At the end of the experimental period (end of the post-
ischaemia 48 h period), blood samples were withdrawn,
centrifuged (5000 rpm, 10 min) to collect serum. Then,
the rats were housed in individual metabolic cages to
collect a 24-h urine specimen to measure urine volume
and urinary creatinine. After that, the rats were sacrificed
by cervical dislocation after being anaesthetized with
sodium pentobarbital (6–70 mg/kg, intraperitoneally),
after which both kidneys were removed. Parts of the
first kidney were used for histological evaluation and
the other parts were immediately frozen and used later
for western blot studies. Parts of the other kidney were
frozen and homogenized in appropriate buffers as per kit
instructions to prepare homogenates, which were stored
at −80 ◦C and used for biochemical analysis.
2.6.  Parameters  of  urine  and  serum  and  creatinine
(Cr) clearance
Serum Cr concentration was determined by the
commercial colorimetric assay kit purchased from the
Cayman Company (Ann Arbor, MI, USA; Cat., no.
700460). The concentration of Cr in urine samples was
determined by the commercial colorimetric assay kit
(Cayman Company, Ann Arbor, MI, USA; Cat., no.
500701). Blood urea nitrogen (BUN) was determined
by analysis with a kinetic reagent (Diagnostic Chemicals
Limited, Cat., no. 283-30). All analyses were performed
in accordance with the manuals provided by the man-
ufacturers. Cr clearance (Ccr) was calculated using the
following equation (Liu et al., 2012):
Ccr (ml/min/kg)Please cite this article in press as: A.A. Shati. Xanthohum
injury by scavenging ROS and inhibition of JAK-2/STAT-3
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=
[
urinary Cr (mg/dl) ×  urinary volume (ml/min)
serum Cr (mg/dl)
]
× [1000/body weight (g)] ×  [1/1440 (min)]. PRESS
 for Science xxx (2016) xxx–xxx
2.7.  Biochemical  measurements  in  renal
homogenates
The levels of malondialdehyde (MDA), a lipid perox-
idation marker, were measured as levels of thiobarbituric
acid reactive substances (TBARS) using a commer-
cial assay kit (Cat No. NWK-MDA01, NWLSS, USA).
Reduced glutathione (GSH) and glutathione disulphide
(GSSG) concentrations were measured using an assay kit
(Cat. No. 703002, Cayman Chemical, Ann Arbor, MI,
USA). Myeloperoxidase (MPO) activity was measured
spectrophotometrically by a commercially available
colorimetric kit purchased from Hycult Biotec. Inc.
(Netherland, Cat. no. HK105-02) using a UV-visible
spectrophotometer (UV-160A, Shimadzu, Japan). Spe-
cial ELISA kits to measure levels IL-6 (Cat No.
ELR-IL6-001, RayBio, MO, USA), TNF-  (ab100785,
Abcam), MIP-2 (Cat. No. KRC1021, Life Technology,
USA), KC (Cat. No. KMC1061, Invitrogen, USA), and
IL-1 (Cat. No. ab100768, Abcam) were used according
to the manufacturer’s instructions.
2.8.  Western  blot
Total proteins of the frozen renal tissue were extracted
with I ml RIPA buffer (150 mM sodium chloride, 1.0%
NP-40 or Triton X-100 0.5%, sodium deoxycholate
0.1% SDS (sodium dodecyl sulphate), 50 mM Tris,
pH 8.0) to which protease and phosphatase inhibitors
were added. The protein concentration in this whole cell
lysate was measured by Bradford assay. The sample,
diluted in loading buffer and heated at 95 ◦C for 5 min,
was then subjected to electrophoresis on 10% SDS-
PAGE gel at 100 V for 2 h (60 g protein/well). After
electrophoresis of the gel and transfer of the proteins to
nitrocellulose membrane, the membranes were rinsed
briefly in Tris-buffered saline containing 0.05% Tween
(TBST) buffer, blocked in blocking buffer (5% milk and
0.5% BSA) for 1 h, and washed three times with TBST
buffer. The membranes were incubated with different
primary monoclonal and polyclonal antibodies: JAK-2
(SC344479, 128 kDa), p-JAK-2 (CS21780, 128 kDa),
STAT-3, p-STAT-3, STAT1 (SC482, 84/91 kDa) and
p-STAT1 (SC-7993, 84/91 kDa)-,  actin (Sc-1616,
43 kDa) 8 hydroxyguanine (8-OHdG, sc-66036) and
4-Hydroxynonenal (4HNE, sc-130083), all of which
were purchased from Santa Cruz Biotechnology,
Santa Cruz, CA, USA and Caspase 3 (32 kDa) andol protects against renal ischaemia reperfusion (I/R)
 inflammatory pathway, J. Taibah Univ. Sci. (2016),
its resultant cleaved large fragment (17 kDa) (9662)
were purchased from Cell signalling, Technology,
USA) (ASP 175, Cell signalling, Technology, USA)
at a dilution of 1:1000 for 2 h and then washed
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nd reacted with corresponding secondary horseradish
eroxidase-conjugated antibodies (Cell Signalling Tech-
ology) for other 2 h. Antigen-antibody complexes were
hen visualized using a Pierce ECL kit (Thermofisher,
SA, Piscataway, NJ) photographed and bands intensi-
ies were quantified using Image J software (1.46R, NIH,
SA). All experiments were performed in triplicate to
epresent the mean plus or minus SD of all data.
.9.  Histopathological  studies
Parts of the kidney were rapidly fixed in 10% neutral
uffered formalin, dehydrated in ascending concentra-
ions of ethyl alcohol (70 to 100%) and then prepared
sing standard procedures for haematoxylin and eosin
taining. Light microscopic examination of multiple tis-
ue sections from each sample was performed and image
epresentatives of the typical histological profile were
xamined.
.10.  Statistical  analysis
Statistical analyses were performed by using Graph-
ad Prism statistical software package (version 6). The
ata are represented as the means ±  SD. All comparisons
ere analyzed by one-way ANOVA followed by post hoc
ukey’s test and were accepted as significant at P  < 0.05.
.  Results
.1.  Markers  of  kidney  functionPlease cite this article in press as: A.A. Shati. Xanthohum
injury by scavenging ROS and inhibition of JAK-2/STAT-3
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Markers of kidney functions are depicted in Fig. 1.
here were no significant changes in the levels of serum
rea and creatinine (Cr) or urinary levels of Cr, urine
olume or Cr clearance between the sham groups that in the renal homogenates of all groups. Values are expressed as the
t P < 0.05. (a) Significantly different when compared to Sham operated
gnificantly different when compared to I/R group.
received normal saline or XN. However, the levels
of serum urea and Cr were significantly (P  < 0.0001)
increased and the urine volume, urinary Cr levels and
Cr clearance were significantly (P  < 0.0001) decreased
in the I/R induced rats compared to sham rats. On the
other hand, the levels of all these parameters showed sig-
nificant improvement towards their normal levels seen
in the sham rats in I/R rats pre-administered with XN.
However, the levels of all these parameters remained
slightly higher than those levels seen in the sham
group.
3.2.  Levels  of  inﬂammatory  IL-6  and  TNF-α
There were no significant changes in the renal
levels of TNF-  and IL-6 between sham rats and
sham rats pre-treated with XN. However, significant
elevations (P  < 0.001) in the levels of TNF-  and IL-6
were noticed in renal homogenates of I/R-induced rats
compared to sham rats. However, pre-administration
of XN prior to the induction of I/R injury resulted in
significant decreases (P  < 0.01) in the levels of both
cytokines, when compared to I/R rats. In spite of this
reduction, ANOVA analysis revealed significantly
higher levels (P  < 0.05) of both IL-6 and TNF-  in
I/R + NX compared to sham (Fig. 2).
3.3.  Levels  of  chemokines  and  adhesion  molecules
As depicted in Fig. 3, XN administration to sham
rats did not significantly affect the renal levels of
IL-1, ICAM-1, MIP-1 and KC compared to shamol protects against renal ischaemia reperfusion (I/R)
 inflammatory pathway, J. Taibah Univ. Sci. (2016),
rats that received normal saline. On the other hand,
I/R resulted in significant elevations of all these
parameters in the renal homogenates of ischaemic rats.
However, significant decreases in the renal levels of
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the all experimental groups of rats. Values are expressed as the means ± SD
 0.05. (a) Significantly different when compared to Sham operated group. (b)
ficantly different when compared to I/R group.
Fig. 4. Activity of myeloperoxidase activity (MPO) in renal
homogenates of all experimental groups of rats. Values are expressed asFig. 3. Levels of inflammatory chemokines in renal homogenates of 
for 10 rats/group. Values were considered significantly different at P <
Significantly different when compared to Sham + XN group. (c) Signi
these parameters were seen in the renal homogenates
of I/R rats pre-administered XN compared to the model
I/R group. ANOVA analysis showed that XN did not
completely normalize the levels of these parameters
and the levels remained significantly higher (P  < 0.05)
than their corresponding levels measured in the renal
homogenates of the sham group.
3.4.  Activity  of  myeloperoxidase  (MPO)  and  levels
of oxidative  stress
There were no significant alterations in the activities
of renal MPO (Fig. 4) and renal levels of MDA,
GSH, GSSG, the ratio of GSH/GSSG (Fig. 5), or the
expression levels of 4HNE and 8-HG (Fig. 6) in sham
groups pre-administered XN compared to the sham
group that received normal saline. However, significant
elevations (P  < 0.05) in the activities of renal MPO
and renal levels of MDA and GSSG, as well as thePlease cite this article in press as: A.A. Shati. Xanthohum
injury by scavenging ROS and inhibition of JAK-2/STAT-3
http://dx.doi.org/10.1016/j.jtusci.2016.09.009
expression levels of 4HNE and 8-HG, with concomitant
significant decreases (P  < 0.05) in the renal levels of
GSH and GSH/GSSG ratio were noticed in the renal
homogenates of I/R rats (Figs. 4–6).ol protects against renal ischaemia reperfusion (I/R)
 inflammatory pathway, J. Taibah Univ. Sci. (2016),
the means ± SD for 10 rats/group. Values were considered significantly
different at P < 0.05. (a) Significantly different when compared to Sham
group. (b) Significantly different when compared to Sham + XN group.
(c) Significantly different when compared to I/R group.
Please cite this article in press as: A.A. Shati. Xanthohumol protects against renal ischaemia reperfusion (I/R)
injury by scavenging ROS and inhibition of JAK-2/STAT-3 inflammatory pathway, J. Taibah Univ. Sci. (2016),
http://dx.doi.org/10.1016/j.jtusci.2016.09.009
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Fig. 5. Levels of malondialdehyde (MDA), reduced glutathione (GSH), glutathione disulfide (GSSG) and the ratio of GSH/GSSG in renal
homogenates of all experimental groups of rats. Values are expressed as the means ± SD for 10 rats/group. Values were considered significantly
different at P < 0.05. (a) Significantly different when compared to Sham group. (b) Significantly different when compared to Sham + XN group. (c)
Significantly different when compared to I/R group.
Fig. 6. Levels of 4-hydroxyguanine (4-HG) and 4-hydroxynonenal (4HNE) in the renal tissue of all experimental groups of rats. Values are expressed
as the means ± SD for 10 rats/group. Values were considered significantly different at P < 0.05. (a) Significantly different when compared to Sham
group. (b) Significantly different when compared to Sham + XN group. (c) Significantly different when compared to I/R group.
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n the re
05. (a) S
ent wheFig. 7. Expression levels of Caspase 3 and Cleaved Caspase fragment i
for 6 rats/group. Values were considered significantly different at P < 0.
different when compared to Sham + XN group. (c) Significantly differ
Significant improvement characterized by a signifi-
cant reduction in the activities of renal MPO and renal
levels of MDA and GSSG, as well as expression levels
of 4HNE and 8-HG, with parallel increases in the renal
levels of GSG and GSH/GSSG ratio, were seen in I/R
rats pre-administered XN compared to sham rats. Among
all, only the renal levels of GSSG and GSH/GSSG ratio
and expression levels of 4HNE and 8-HG were com-
pletely normalized, and their levels were not significantly
different with those measured in the sham group.
3.5.  Expression  levels  of  Caspase  3  and  cleaved
Caspase  3
The expression levels of Caspase 3 remained constant
and not significantly different between all experimental
groups of rats. However, the levels of cleaved Caspase
3 were barely detected in the sham groups that received
normal saline or XN. I/R significantly raised (P  < 0.001)Please cite this article in press as: A.A. Shati. Xanthohum
injury by scavenging ROS and inhibition of JAK-2/STAT-3
http://dx.doi.org/10.1016/j.jtusci.2016.09.009
the expression of cleaved Caspase 3 compared to sham
group. A significant reduction in the expression levels of
cleaved Caspase 3 was seen in I/R rats pre-treated with
XN (Fig. 7).nal tissue of all groups of rats. Values are expressed as the means ± SD
ignificantly different when compared to Sham group. (b) Significantly
n compared to I/R group.
3.6.  Activation  of  JAK-2/STAT-3
While there were no significant changes in the
levels of JAK-2 and STAT-3 between the sham
and sham + XN experimental groups, I/R significantly
enhanced (P  < 0.001) the expression levels of both
p-JAK-2 and p-STAT-3, which resulted in their activa-
tion (Fig. 8). On the other hand, pre-administration of
XN prior to I/R injury resulted in significant decreases
(P < 0.001) in the phosphorylation levels of both JAK-2
and STAT-3 compared to I/R rats, but they remained sig-
nificantly higher (P  < 0.001) than their expression levels
in sham rats (Fig. 8).
3.7.  Histopathological  ﬁndings
Kidney sections obtained from all groups of rats are
presented in Fig. 9. The sections of the sham groups that
received normal saline or XN (A and B, respectively)ol protects against renal ischaemia reperfusion (I/R)
 inflammatory pathway, J. Taibah Univ. Sci. (2016),
showed normal histological structure of the renal cor-
puscles and renal tubules. The renal corpuscle consisted
of a tuft of blood capillaries surrounded by Bowmann’s
capsule. The latter has a parietal layer lined by squamous
ARTICLE IN PRESS+ModelJTUSCI-336; No. of Pages 13
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Fig. 8. Expression levels and activation ratios of JAK-2 and STAT-3 in the renal tissue of all groups of rats. Activation ratio was calculated as
e ing exp
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txpressed levels of phosphorylated to unphosphorylated forms after be
or 6 rats/group. Values were considered significantly different at P < 0.
ifferent when compared to Sham + XN group. (c) Significantly differ
ells and a visceral layer lined by podocytes. Sections of
/R rats (C) showed a high degree of loss of the brush
order in renal tubules, tubular dilatation, severe tubular
ecrosis and apoptosis, dilatation of Bowman’s capsule
nd increased urinary space. In addition, degeneration
nd shrinkage of the glomerular capillaries was evident.
n the other hand, XN pre-treatment for 28 days prior
he I/R injury significantly ameliorated the pathological
ndings seen in the renal tissues of the I/R injured group,
nd resulted in almost normal architectures as seen in the
ontrol group. However, some cortical tubules were still
ilated and mild glomerular capillary degeneration and
ubular necrosis was still seen.
.  DiscussionPlease cite this article in press as: A.A. Shati. Xanthohum
injury by scavenging ROS and inhibition of JAK-2/STAT-3
http://dx.doi.org/10.1016/j.jtusci.2016.09.009
Ischaemic acute renal failure (IARF), which is mainly
aused by the reduction of blood supply to the kidney,
s a common clinical event. Despite current medica-
ions and supportive preventive strategies, this diseaseressed normalized to  actin. Values are expressed as the means ± SD
ignificantly different when compared to Sham group. (b) Significantly
n compared to I/R group.
continues to be associated with significant morbidity
and mortality [15]. Indeed, complications of renal fail-
ure associated with ischaemia/reperfusion (I/R) during
or after surgical and anaesthesia procedures are still
major problems [16]. Thus, improving the abilities of
the kidneys to tolerate I/R injury associated with surgery
would have important implications [17]. Hence, this
study aimed to investigate the protective effect of Xan-
thohumol (XN) against I/R induced renal damage and
to investigate its molecular mechanisms of protection.
Interestingly, the results of this study showed that in addi-
tion to its antioxidant potential, XN ameliorates renal I/R
damage through the inhibition of JAK/STAT phosphory-
lation, which could explain its potent anti-inflammatory
action.
To validate our model and safety of XN, the I/Rol protects against renal ischaemia reperfusion (I/R)
 inflammatory pathway, J. Taibah Univ. Sci. (2016),
model group showed severe renal damage associated
with a decline in kidney function, increase of serum
urea and creatinine, and decrease of urinary creati-
nine and decreased creatinine clearance. These changes
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Fig. 9. Photomicrographs of kidneys obtained from all groups of rats. (A) and (B) were taken from Sham and Sham + XN, respectively. These
groups show normal architecture of kidney with prominent Bowman’s capsule, epithelial cells and normal tubules. (C) was taken from I/R rat.
The kidney sections of this rat shows mild thickening of the basement membrane along with changes in the density of mesenchyme, atrophy and
degeneration of glomerular capillaries with increased Bowman’s space (urinary space) and tubular necrosis and apoptosis. Glomerular capillaries
nd show
kage ofshowed severe shrinkage and damage. (D) was taken from treated rat a
with the presence of some degeneration in the tubules and slight shrin
correlated to extensive histopathological damages such
as cellular vacoulation, apoptosis, tubular necrosis,
glomerular damage and tubulointerstitial injury. Such
effects were completely absent in the sham rats that
received normal saline or XN, indicating success of our
model, safety of our drug on renal function and con-
firming that the damage occurred after induction of I/R
injury.
However, endothelial cell injury, generation of
reactive oxygen species (ROS), and apoptosis have been
implicated in the pathogenesis of the early phases of
renal I/R injury [2]. During renal IR, hypoxanthine and
xanthine accumulate within the ischaemic cells [18,19]
and reperfusion stimulates the transformation of these
metabolites to uric acid and excessive production of ROS
[18,19]. Another source of ROS could originate from
the massive early influx of neutrophils, which results
in the release of ROS through the action of NADPH
oxidase or MPO system [3,4]. It has been shown thatPlease cite this article in press as: A.A. Shati. Xanthohum
injury by scavenging ROS and inhibition of JAK-2/STAT-3
http://dx.doi.org/10.1016/j.jtusci.2016.09.009
excessive amount of ROS can cause cellular oxidative
damage through inhibition of mitochondrial oxidative
phosphorylation, ATP depletion, increasing intracellu-
lar calcium and activation of membrane phospholipids normal architecture of glomerular capillaries, intact epithelial cells
 the glomerular capillaries.
proteases [2]. Moreover, these ROS damage the cells
by the peroxidation of membrane lipids and causing
oxidative damage to the cellular proteins and DNA, con-
tributing to apoptosis and cell death [20] to worsen the
condition, and reduced levels of intracellular enzymatic
and non-enzymatic antioxidants have been reported
during and after early phases of renal I/R injury [21].
Therefore, inhibiting this pathway by preventing free
radical production, or stimulating antioxidants and ROS
scavenger levels are interesting strategies to protect the
renal tissue during I/R. Indeed, numerous studies have
shown beneficial effects of natural free radical scav-
engers and antioxidants on IRI [18,22]. In the current
study, XN protected the animals from ROS oxidative
damage by enhancing the levels of reduced glutathione
(GSH) and reducing levels of lipid peroxidation as
measured by MDA. In addition, XN reduced subcellular
damage as indicated by decreased levels of 4-HNE and
8-HG, common markers of oxidative lipid peroxidationol protects against renal ischaemia reperfusion (I/R)
 inflammatory pathway, J. Taibah Univ. Sci. (2016),
and DNA damage as a result of ROS, as depicted
by western blot data. Thus, these results suggest that
the protective effect of XN against renal I/R involves
an antioxidant scavenger capacity. However, further
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nvestigation on the effect of XN on GSH synthesis
athway should be considered, and were not performed
n this study. These results are supported by previous
tudies that have shown the antioxidant potential of XN
n various conditions where XN could directly scavenge
OS [23]. Similar to our findings, Hartkorn et al. [24]
nd Dorn et al. [13] reported an antioxidant preven-
ative effect of XN against liver induced I/R injury.
urthermore, XN has cellular defence mechanisms
gainst oxidative damages induced by chemicals [25].
oreover, XN protects human LDL from oxidation
26].
On the other hand, accumulated evidence shows that
ARF is also an inflammatory disease, as manifested by
he infiltration of leucocytes, up-regulation of chemo-
actic factors by endothelial cells and generation of
ro-inflammatory mediators by renal tubular epithelial
ells [27]. Leucocytes are usually recruited to the sites
f injury by pro-inflammatory cytokines interleukin-1,
IL-1), g-interferon (IFN-g) and TNF-a [2] During renal
/R injury, renal tubular epithelial cells also facilitate
he process by generating proinflammatory cytokines
ncluding monocyte chemoattractant protein-1 (MCP-
), TNF-a, IL-1b, IL-6, IL-18 [3]. In addition, enhanced
xpression of adhesion molecules such as intracellular
ell adhesive molecule (ICAM-1) (murine homologue is
eratinocyte-derived chemokine (KC)) and macrophage
nflammatory protein-2 (MIP-2) exacerbates the infil-
ration of neutrophils to the ischaemic tissue [3].
ro-inflammatory cytokines such as interleukin 6 (IL6)
28] and activation of Janus kinase/signal transducer
nd activator of transcription (JAK/STAT) pathway have
een implicated to play an essential role in the pathogen-
sis of I/R injury [17]. Moreover, it has been reported
hat the activation of JAK/STAT pathway causes the
elease of many pro-inflammatory cytokines that are
nvolved in the progression of renal I/R, including
CP-1, ICAM and KC [17,29,30]. Among all, recent
vidence has shown that the JAK-2/STAT-3 pathway
s activated during the early phases of renal I/R and is
 determinant of the progression of I/R inflammation
17,29,30], and investigating the role of this pathway
n the anti-inflammatory action of XN was one of our
argets.
In the current study, in accordance with previ-
usly mentioned findings, I/R injury was associated
ith enhanced levels of major cytokines and adhe-
ion molecules with a concomitant increase in MPOPlease cite this article in press as: A.A. Shati. Xanthohum
injury by scavenging ROS and inhibition of JAK-2/STAT-3
http://dx.doi.org/10.1016/j.jtusci.2016.09.009
ctivity and activation of the JAK-2/STAT-3 pathway,
s indicated by their enhanced phosphorylated forms
etected by western blot. These results further confirmed
he previous findings that activation of JAK-2/STAT-3 PRESS
 for Science xxx (2016) xxx–xxx 11
pathway plays an essential role during renal I/R injury
and is involved in neutrophilic infiltration damage
[17,29,30]. On the other hand, beside its antioxidant
potential, XN ameliorated I/R cell damage and resulted
in decreased levels of all inflammatory cytokines and
adhesion molecules. Numerous mechanisms of action
have been suggested for the anti-inflammatory effect
of XN in various disease conditions, such as inhibition
of inducible NO synthase (iNOS) [31], suppression of
NFB activation [32,33], inhibiting the binding activ-
ity of STAT-1  and interferon regulatory factor-1 [32],
modulating the T-cell mediated response [34], inhibi-
tion of cyclooxygenase 2 (COX-2) [35] and decreasing
prostaglandin-E2 (PGE2) expression [36]. For the first
time, this study shows a novel mechanism by which
XN may ameliorate renal I/R induced inflammation and
renal damage through inhibition of the JAK-2/STAT-3
pathway.
On the other hand, a mounting body of evidence now
indicates that apoptosis is the major mechanism of early
tubular cell death in both clinical acute renal failure
and experimental I/R injury [21]. A multitude of path-
ways, including the intrinsic (Bcl-2 family, cytochrome
c and caspase 9), and regulatory (p53 and NF-k) fac-
tors, seem to be activated by I/R [21]. ROS species
are believed to activate both of these pathways. On
the other hand, the acute inflammatory response ini-
tiated by I/R contributes to the death of renal cells
as a combination of both necrosis and apoptosis [2].
In this study, apoptosis and necrosis were seen in the
histopathological slides obtained from I/R rats. Fur-
thermore, enhanced expression of cleaved caspase 3 is
clearly demonstrates activation of apoptotic cascade. XN
completely ameliorated the expression levels of activated
Caspase 3 and resulted in improvement of glomeru-
lus and epithelium tissue of renal tubules, suggesting
decreased levels of necrosis and apoptosis. Recent evi-
dence has shown that inhibition of JAK-2 or STAT-3
by AG490 or dominant-negative STAT-3 adenovirus,
respectively, leads to increased ERK activation and sur-
vival of mouse proximal tubular epithelial (TKPTS) cells
during severe oxidative stress [37]. Based on these find-
ings and its antioxidant effect, XN could enhance the
survival of tubular epithelial cells by decreasing the
activation of JAK-2/STAT-2 pathway. However, such
findings should be confirmed in further studies since XN
has both antioxidant and anti-inflammatory effects and it
is not clear whether the mechanism responsible for such
decreases in phosphorylated JAK and STAT-1 are due to
a direct effect of XN on JAK/STAT tyrosine activitiesol protects against renal ischaemia reperfusion (I/R)
 inflammatory pathway, J. Taibah Univ. Sci. (2016),
or due to decreased ROS and/or inflammatory mediators
found in this study.
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5.  Conclusion
Based on our results, there was a protective effect
of XN against renal I/R injury and the mechanisms
of protection involved ROS scavenging and an anti-
inflammatory effect mediated by inhibition of the
JAK-2/STAT-3 pathway. Further experiments and clini-
cal trials remain necessary to validate these findings.
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